Literature DB >> 6109015

Adrenergic regulation of blood glucose levels: possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release.

T Nakadate, T Nakaki, T Muraki, R Kato.   

Abstract

We have demonstrated that while phenoxybenzamine and prazosin (10(-7)-10(-4) mol/kg i.p.) are ineffective in inhibiting the hyperglycemia induced by alpha adrenergic agonists in fed male mice, phentolamine, yohimbine and dihydroergotamine are effective. These results suggest the involvement of alpha-2 type adrenergic receptors in the regulation of the plasma glucose levels. When attempting to elucidate the mechanism of such differences, we found that the release of immunoreactive insulin induced by epinephrine was markedly stimulated by phentolamine, yohimbine and dihydroergotamine, whereas phenoxybenzamine and prazosin had little effect. The ineffectiveness of these two compounds to inhibit the hyperglycemia induced by alpha adrenergic agonists indicates that the postsynaptic alpha adrenergic receptors which suppress the secretion of immunoreactive insulin from B cells of pancreatic islets are not blocked and that the alpha adrenergic receptors which control immunoreactive insulin secretion differ from the classical postsynaptic alpha adrenergic receptors and more closely resemble presynaptic alpha-2 adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109015

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist.

Authors:  R F Schafers; H L Elliott; C A Howie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors.

Authors:  A Schulz; A Hasselblatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

3.  Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

4.  Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release.

Authors:  A Schulz; A Hasselblatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

5.  Modulation of the hypothermic and hyperglycaemic effects of 8-OH-DPAT by alpha 2-adrenoceptor antagonists.

Authors:  M J Durcan; K M Wozniak; M Linnoila
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  Effect of clonidine on glucose, insulin and glucagon responses to a protein meal in type 2 diabetics.

Authors:  S Ferlito; G Indelicato; S Di Vincenzo; F Del Campo; A La Vignera; C Fichera
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

7.  Inhibitory alpha 2-adrenergic mechanism regulating gastric secretion in pylorus-ligated rats.

Authors:  T Nakadate; T Nakaki; T Muraki; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

8.  Evidence that the novel imidazoline compound FT005 is an alpha(2)-adrenoceptor agonist.

Authors:  Scott Slough; Gerald Guillaumet; Peter V Taberner
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets.

Authors:  T Nakaki; T Nakadate; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

10.  Influences of urethane anesthesia on indomethacin-induced gastric mucosal lesions in rats. Relation to blood glucose levels.

Authors:  K Takeuchi; H Niida; T Ohuchi; S Okabe
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.